» Articles » PMID: 36210887

Distribution Width of Red Blood Cells and Related Factors Among Patients with End-Stage Renal Disease in Addis Ababa, Ethiopia

Overview
Journal J Blood Med
Publisher Dove Medical Press
Specialty Hematology
Date 2022 Oct 10
PMID 36210887
Authors
Affiliations
Soon will be listed here.
Abstract

Background: RDW is critical to the clinical diagnosis and progression of ESRD. There is currently little data on the relationship between RDW and ESRD in sub-Saharan Africa. Because of this, the present study evaluates RDW in patients with ESRD and associated factors in Addis Ababa, Ethiopia.

Methods: The hospital-based cross-sectional study design was conducted on a total of 83 patients. RDW, MCV, SCR, BUN, GFR, FBS and serum albumin were determined. Blood pressure (mmHg), weight (kg), height (m), MUAC (cm) and BMI (kg/m2) were also measured. Data entry was via Epi-data version 3.4 and analyzed with SPSS version 26.0. A multivariate logistic regression analysis with a p-value < 0.05 at a 95% confidence interval was used to identify the associated factors of RDW.

Results: A total of 83 ESRD patients participated, with a response rate of 95.4%. RDW ranged from 15.5% to 23.6% with a mean of 17.40% + 1.46%. Anisocytosis was present in 98.8% of patients. Of 83 patients, 66.3% were hypertensive, 20.5% had diabetes, and the remaining 13.3% had other conditions (glomerulonephritis and peripheral vascular disease). The mean GFR value was 5.20 mL/min/1.73 + 1.58. RDW showed a significant association with GFR (AOR: 4.6, 95% CI [1.27, 20.74], P = 0.047), alcohol consumption (AOR: 13.4, P = 0.012, 95% CI [1.97, 22.62]), recurrent kidney disease (AOR=25.6, P=0.016, 95% CI [1.85, 53.71]) and use of medication (AOR=00.2, P=0.044), 95% CI [0.03, 0.95]).

Conclusion: RDW showed a significant association with GFR, recurrent kidney disease, alcohol consumption, and medication use in hemodialysis-dependent ESRD patients. The mechanisms of RDW disruption in ESRD patients need further investigation.

References
1.
Patel K, Ferrucci L, Ershler W, Longo D, Guralnik J . Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med. 2009; 169(5):515-23. PMC: 2765040. DOI: 10.1001/archinternmed.2009.11. View

2.
Li Z, Chen L, Yuan H, Zhou T, Kuang Z . Relationship between red blood cell distribution width and early-stage renal function damage in patients with essential hypertension. J Hypertens. 2014; 32(12):2450-5. DOI: 10.1097/HJH.0000000000000356. View

3.
Vashistha T, Streja E, Molnar M, Rhee C, Moradi H, Soohoo M . Red Cell Distribution Width and Mortality in Hemodialysis Patients. Am J Kidney Dis. 2016; 68(1):110-21. PMC: 4921311. DOI: 10.1053/j.ajkd.2015.11.020. View

4.
Pilling L, Atkins J, Duff M, Beaumont R, Jones S, Tyrrell J . Red blood cell distribution width: Genetic evidence for aging pathways in 116,666 volunteers. PLoS One. 2017; 12(9):e0185083. PMC: 5619771. DOI: 10.1371/journal.pone.0185083. View

5.
Montagnana M, Danese E . Red cell distribution width and cancer. Ann Transl Med. 2016; 4(20):399. PMC: 5107391. DOI: 10.21037/atm.2016.10.50. View